Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
XOMA XOMA Corp
- Stocks
- Healthcare
- NASDAQ: XOMA
Price (delayed)
$26.17
Market cap
$313.17M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.1
Enterprise value
$335.95M
XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company's portfolio of partner-funded programs spans multiple stages
Highlights
XOMA's net income has surged by 87% YoY and by 71% QoQ
The EPS has soared by 72% YoY and by 33% from the previous quarter
The company's quick ratio fell by 45% YoY but it rose by 9% QoQ
Key stats
What are the main financial stats of XOMA
Market
Valuations
Earnings
Shares outstanding
11.97M
Market cap
$313.17M
Enterprise value
$335.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.7
Price to sales (P/S)
7.3
EV/EBIT
134.22
EV/EBITDA
100.98
EV/Sales
7.83
Revenue
$42.91M
Gross profit
$42.91M
Operating income
-$27.04M
Net income
-$5.6M
EBIT
$2.5M
EBITDA
$3.33M
Free cash flow
-$29.82M
Per share
Balance sheet
Liquidity
EPS
-$1.1
EPS diluted
-$1.14
Free cash flow per share
-$2.49
Book value per share
$7.06
Revenue per share
$3.59
TBVPS
$15.66
Total assets
$212.75M
Total liabilities
$128.12M
Debt
$114.45M
Equity
$84.63M
Working capital
$92.79M
Debt to equity
1.35
Current ratio
5.54
Quick ratio
4.87
Net debt/EBITDA
6.85
Margins
Efficiency
Dividend
EBITDA margin
7.8%
Gross margin
100%
Net margin
-13%
Operating margin
-63%
Return on assets
-2.5%
Return on equity
-6.4%
Return on invested capital
1.3%
Return on capital employed
1.3%
Return on sales
5.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XOMA stock price
How has the XOMA stock price performed over time
Intraday
4.68%
1 week
5.69%
1 month
13.59%
1 year
9.13%
YTD
-0.42%
QTD
31.31%
Financial performance
How have XOMA's revenue and profit performed over time
Revenue
$42.91M
Gross profit
$42.91M
Operating income
-$27.04M
Net income
-$5.6M
Gross margin
100%
Net margin
-13%
The net margin has surged by 98% year-on-year and by 81% since the previous quarter
XOMA's operating margin has soared by 91% YoY and by 55% from the previous quarter
XOMA's net income has surged by 87% YoY and by 71% QoQ
The revenue has soared by 51% from the previous quarter
Price vs fundamentals
How does XOMA's price correlate with its fundamentals
Growth
What is XOMA's growth rate over time
Valuation
What is XOMA stock price valuation
P/E
N/A
P/B
3.7
P/S
7.3
EV/EBIT
134.22
EV/EBITDA
100.98
EV/Sales
7.83
The EPS has soared by 72% YoY and by 33% from the previous quarter
XOMA's price to book (P/B) is 14% more than its 5-year quarterly average of 3.1 and 7% more than its last 4 quarters average of 3.3
The company's equity rose by 3.3% QoQ and by 2.8% YoY
The stock's P/S is 74% below its 5-year quarterly average of 26.6 and 43% below its last 4 quarters average of 12.2
The revenue has soared by 51% from the previous quarter
Efficiency
How efficient is XOMA business performance
The company's return on invested capital has surged by 122% QoQ and by 104% YoY
The ROS has soared by 115% from the previous quarter and by 101% YoY
The return on assets has surged by 90% year-on-year and by 71% since the previous quarter
XOMA's ROE has soared by 85% YoY and by 71% from the previous quarter
Dividends
What is XOMA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for XOMA.
Financial health
How did XOMA financials performed over time
XOMA's total assets is 66% greater than its total liabilities
The company's quick ratio fell by 45% YoY but it rose by 9% QoQ
XOMA's current ratio is down by 41% year-on-year but it is up by 8% since the previous quarter
The debt is 35% greater than the equity
The company's debt to equity fell by 8% YoY and by 8% QoQ
The debt has declined by 5% year-on-year and by 4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.